# OnCo record lymphoma-tx-radiotherapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-radiotherapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-radiotherapy" ;
  schema:name "Radiotherapy in lymphoma: involved-site fields, 24 Gy, 4 Gy and total skin electron therapy"@en ;
  schema:alternateName "Involved-site radiotherapy"@en, "ISRT"@en, "Involved-field radiotherapy"@en, "Low-dose radiotherapy lymphoma"@en, "Boom-boom radiotherapy"@en ;
  schema:description "Lymphoma is one of the most radiation-sensitive cancers there is, so the doses are low and the fields are small. Two doses of 2 Gy can shrink a painful node in a fortnight; 24 Gy can cure a stage I follicular lymphoma."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-radiotherapy/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00964>, <https://doi.org/10.1200/JCO.2016.68.6394> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/palliative-radiotherapy/>, <https://onco.cc/technologies/proton-therapy/>, <https://onco.cc/technologies/total-skin-electron-therapy/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/pet-adapted-therapy/>, <https://onco.cc/technologies/electron-beam-therapy-systems/> ;
  onco:terms <https://onco.cc/terms/deauville/>, <https://onco.cc/terms/lugano-classification/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014/>, <https://onco.cc/key-papers/paper-ielsg37-pmbcl-martelli-jco-2024/> .